Jul 29, 2026 7:30am EDT PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
Jan 12, 2026 9:15am EST Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference